GLP-1 drugs made obesity genetics a dinner-table subject.
Why this topic GLP-1 drugs went from clinic to conversation in two years.
Counted in Europe PMC, where the title or abstract names both this topic and that rsID. The number is papers, not evidence of a cause.
TFAP2B
Adiposity
3 papers →APOA5
Triglyceride levels
2 papers →GIPR
Obesity
1 paper →GIPR
Obesity
1 paper →FTO
Obesity-related traits
1 paper →Europe PMC, title and abstract only, searched for “semaglutide”, “GLP-1 receptor agonist”, “tirzepatide”, “weight loss intervention” alongside each published rsID. Full text was not counted: it returns every paper with an rsID buried in a supplementary table. Recounted monthly.